Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy. (Record no. 17812474)

MARC details
000 -LEADER
fixed length control field 01434 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515111722.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200808s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1476-5500
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/cgt.2008.17
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Rautsi, O
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20080806
245 00 - TITLE STATEMENT
Title Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer gene therapy
Date of publication, distribution, etc. May 2008
300 ## - PHYSICAL DESCRIPTION
Extent 303-14 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CHO Cells
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Death
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cricetinae
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cricetulus
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ganciclovir
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genetic Therapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Herpesvirus 1, Human
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peptide Fragments
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymidine Kinase
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element tat Gene Products, Human Immunodeficiency Virus
General subdivision chemistry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lehmusvaara, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ketola, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Määttä, A-M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wahlfors, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pellinen, R
773 0# - HOST ITEM ENTRY
Title Cancer gene therapy
Related parts vol. 15
-- no. 5
-- p. 303-14
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/cgt.2008.17">https://doi.org/10.1038/cgt.2008.17</a>
Public note Available from publisher's website

No items available.